We are live on ! Find out more
DA

Doliver Advisors Portfolio holdings

AUM $442M
1-Year Est. Return 34.09%
This Fund
S&P 500
This Quarter Est. Return
+5.17%
1 Year Est. Return
+34.09%
3 Year Est. Return
+81.03%
5 Year Est. Return
+128.47%
10 Year Est. Return
+193.24%
AUM
$253M
AUM Growth
+$4.04M
Cap. Flow
-$3.94M
Cap. Flow %
-1.56%
Top 10 Hldgs %
69.06%
Holding
176
New
28
Increased
42
Reduced
71
Closed
26

Sector Composition

Rank Sector Weight
1 Energy 38.58%
2 Financials 6.79%
3 Communication Services 6.19%
4 Healthcare 4.57%
5 Consumer Discretionary 3.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CELG
176
DELISTED
Celgene Corp
CELG
-3,403
Closed -$344K

Similar funds

Doliver Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Doliver Advisors held 176 positions worth $253M, up 1.6% from $249M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Doliver Advisors's Q4 2019 filing shows 28 new, 42 increased, 71 reduced and 26 closed positions. Its largest new stake was Cohen & Steers Infrastructure Fund: 96,649 shares worth $2.53M. The largest sale was iShares Core S&P 500 ETF, an estimated $6.05M.

By sector, the portfolio is most concentrated in Energy at 39% of assets, down from 39% a quarter earlier, followed by Financials and Communication Services.

  • Doliver Advisors's largest Q4 2019 buy was Cohen & Steers Infrastructure Fund: 96,649 shares worth $2.53M.
  • Doliver Advisors added most to Gabelli Dividend & Income Trust in Q4 2019, an estimated $772K increase.
  • Doliver Advisors's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $6.05M.
  • Doliver Advisors fully exited ClearBridge MLP and Midstream Fund Inc. in Q4 2019, selling an estimated $1.16M.
  • Doliver Advisors's ten largest holdings make up 69% of its $253M portfolio in Q4 2019.
  • Doliver Advisors opened 28 new positions and closed 26 in Q4 2019.
  • Doliver Advisors's portfolio value rose 1.6% quarter-over-quarter to $253M.

Based on Doliver Advisors's 13F filing for Q4 2019, filed 27 Jan 2020.